TrialBMC cancer2015

Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2).

Naoyoshi Onoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.